# Biomat USA Inc – FDA Inspection, Jan 28, 2026

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/12a8f1b3-c33f-4882-bffd-fe6dbc9fec68
Source feed: FDA_Inspections

> FDA inspection 1300278 of Biomat USA Inc, January 28, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300278
- Company Name: Biomat USA Inc
- Inspection Date: 2026-01-28
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Cincinnati District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1201904 - 2023-03-16

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nancy-l-neiger/c3209528-eeb3-4a5f-88b1-f503798ed4c5)

Company: https://www.keypedia.com/companies/biomat-usa-inc/2d97f6ea-eda7-46ea-a392-ad3c58a66386

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22
